Literature DB >> 4518342

The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.

J C Downie.   

Abstract

The sequential development of the immune response in nasal washings was studied in 54 volunteers immunized with either attenuated or inactivated influenza B/Eng/13/65 virus vaccines.Eleven of the 15 volunteers given the inactivated vaccine by deep subcutaneous inoculation showed no rise in nasal wash protein or immunoglobins due to the immunization procedure nor was specific neutralizing antibody detected in their nasal washings after immunization. Neutralizing antibody was detected in nasal washings of three volunteers in this group who also showed a 20-fold or greater increase in serum haemagglutinin-inhibiting antibody after immunization and in one volunteer who had antibody present in pre-trial nasal washings.Eleven of 15 volunteers who were successfully infected by the live attenuated vaccine showed a characteristic rise in protein and IgA and IgG immunoglobin concentrations in nasal washings 5-14 days after the administration of the live virus vaccine. Neutralizing antibody was detected in the nasal washings of these 11 volunteers and appeared at the same time as or 1-2 days after the initial rise of protein and immunoglobin. Neutralizing antibody was also detected in the nasal washings of one other volunteer who did not show a rise in protein or immunoglobin concentration in nasal washings after immunization.IgA was detected (>/= 3 mg./100 ml.) in the majority (84%) of nasal wash specimens which had a protein concentration of 0.2 mg./ml. or greater while IgG was not detected (>/= 4.5 mg./100 ml.) until the protein concentration rose to 0.4 mg./ml. or greater. The geometric mean concentration for normal nasal wash protein in this study was 0.3 +/- 0.1 mg./ml.Regression analysis indicated that the concentrations of both IgA and IgG immunoglobins were directly proportional to the protein concentration in nasal washings but that this relationship varied considerably between individuals.Absorption studies indicated that neutralizing and haemagglutinin-inhibiting antibodies in nasal secretion to influenza B/Eng/13/65 virus were predominantly associated with the IgA class of immunoglobin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4518342      PMCID: PMC2130575          DOI: 10.1017/s0022172400046416

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  25 in total

1.  The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers.

Authors:  R D Rossen; A L Schade; W T Butler; J A Kasel
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

2.  Influenza virus neutralizing antibody in human respiratory secretions.

Authors:  R H Waldman; J J Mann; J A Kasel
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

3.  The mechanism of appearance of immunoglobulin A in nasal secretions in man.

Authors:  W T Butler; R D Rossen; T A Waldmann
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

4.  Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.

Authors:  R H Alford; R D Rossen; W T Butler; J A Kasel
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

5.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Protein composition of nasal secretion during respiratory virus infection.

Authors:  R D Rossen; W T Butler; T R Cate; C F Szwed; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

8.  Quantitative hemadsorption, a new assay technique. II. Assay of neutralizing antibodies to hemadsorbing viruses.

Authors:  N B Finter
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

9.  The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva.

Authors:  M A South; M D Cooper; F A Wollheim; R Hong; R A Good
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

10.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  4 in total

1.  Pathological aspects of immunization of mice against influenza virus infection.

Authors:  A Baskerville; G Thomas; S Peacock
Journal:  Br J Exp Pathol       Date:  1975-02

2.  The administration of drugs and vaccines by the intranasal route.

Authors:  D S Freestone; A L Weinberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

3.  Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

Authors:  K S Chen; D B Burlington; G V Quinnan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  Measles antibodies in the saliva of children with subacute sclerosing panencephalitis.

Authors:  W Sobczyk; I Polna; J Kulczycki; H Horbowska
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.